Enlivex Therapeutics Ltd. (ENLV) NASDAQ

0.77

-0.053(-6.42%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap24M
Enterprise Value21.23M
P/E Ratio-1.46
PEG Ratio-0.29
Price/Sales Ratio0
Price/Book Ratio1.06
Enterprise/Revenue0
Enterprise/EBITDA-1.12

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.61
Return On Equity-0.63

Income Statement

Revenue0
Revenue/Share0
Gross Profit-545,000
EBITDA-14.47M
Net Income-15.01M
Diluted EPS-0.73

Balance Sheet

Total Cash18.32M
Total Cash/Share0.76
Total Debt701,000
Total Debt/Equity0.04
Current Ratio6.43
Book Value Per Share0.73

Price History

52-Week Change-37.15
52-Week High2.1
52-Week Low0.74
Moving Average 50 Days1
Moving Average 200 Days1.07

Statistics

Average Volume3.82M
Shares Outstanding24.3M
% Held by Institutions3.79

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:8
Last Split DateMarch 06, 2019